SLBT.US SL Science Holding Limited Ordinary Shares
- Market cap
- USD 356M
- P/E
- -
- P/B
- 57.88x
- ROE
- -167.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is SLBT.US undervalued?
Graham numberThe Graham number of SL Science Holding Limited Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SL Science Holding Limited Ordinary Shares fundamental analysis
No fundamental analysis for SL Science Holding Limited Ordinary Shares yet.
SL Science Holding Limited Ordinary Shares stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limit…
Full company profileSL Science Holding Limited Ordinary Shares financial statements
SL Science Holding Limited Ordinary Shares annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 879K | 3.36M | 2.20M |
| Gross Profit | 738K | 1.93M | 775K |
| Operating Income | 96.8K | -1.20M | -3.84M |
| EBITDA | 134K | -1.15M | -3.74M |
| Net Income | 399K | -1.19M | -3.82M |
| EPS | 0.00 | 0.00 | -0.01 |
| Balance Sheet | |||
| Total Assets | 4.24M | 5.93M | 2.82M |
| Total Liabilities | 668K | 205K | 533K |
| Shareholders' Equity | 3.57M | 5.73M | 2.28M |
| Cash & Short-term Investments | 277K | 3.68M | 1.26M |
| Total Debt | 550K | - | 213K |
| Cash Flow | |||
| Operating Cash Flow | -2.45M | 280K | -1.91M |
| Capital Expenditure | 183K | 7.97K | 320K |
| Free Cash Flow | -2.64M | 272K | -2.23M |
| Ratios | |||
| ROE | 11.2% | -20.8% | -167.2% |
| ROA | 9.4% | -20.1% | -135.6% |
| Net Profit Margin | 45.4% | -35.4% | -173.8% |
| Debt to Equity | 0.15x | - | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SL Science Holding Limited Ordinary Shares dividends
SL Science Holding Limited Ordinary Shares has not paid dividends in the last 3 fiscal years.
Who owns SL Science Holding Limited Ordinary Shares
- Insiders 59.55%
- Institutions 0.28%
- Public & others 40.17%
- Shares outstanding 561M
Top funds holding SLBT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 338K | 0.06% | 0.00% | Aug 2026 |
Top institutions holding SLBT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Geode Capital Management, LLC | 193K | 0.03% | 0.00% | Jun 2026 |
| L1 Global Manager Pty Ltd | 150K | 0.03% | 0.00% | Jun 2026 |
| RiverNorth Capital Management, LLC | 130K | 0.02% | 0.00% | Jun 2026 |
| SkyView Investment Advisors, LLC | 42.0K | 0.01% | 0.00% | Jun 2026 |
| Heights Capital Management Inc | 20.0K | 0.00% | 0.00% | Jun 2026 |
| Lynx Capital Group LTD | 17.1K | 0.00% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 14.5K | 0.00% | 0.00% | Jun 2026 |
| UBS Group AG | 12.5K | 0.00% | 0.00% | Jun 2026 |
| Advisor Group Holdings, Inc. | 286.00 | 0.00% | 0.00% | Jun 2026 |
SL Science Holding Limited Ordinary Shares company profile
- Company name
- SL Science Holding Limited Ordinary Shares
- Ticker
- SLBT.US
- ISIN
- KYG8191L1169
- Exchange
- USA Stocks
- Listed since
- Jun 15, 2026
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 14
- Fiscal year end
- December
- Address
- No. 479, Chongyang Rd., Taipei, Taiwan, 115010
- Phone
- 886 2 2651 6826
- Website
- sl-bio.com
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
SL Science Holding Limited Ordinary Shares management
2- Mr. Ching-Dong WangFounder, Chairman & CEO · born 1972
- Mr. Ray LeungCFO & Director · born 1982